Use of PKC inhibitors in transplantation

Details for Australian Patent Application No. 2007333313 (hide)

Owner Novartis AG

Inventors Lake, Philip; Korn, Alexander; Maibucher, Axel

Agent Davies Collison Cave

Pub. Number AU-A-2007333313

PCT Pub. Number WO2008/073770

Priority 60/868,991 07.12.06 US

Filing date 5 December 2007

Wipo publication date 19 June 2008

International Classifications

A61K 31/4468 (2006.01) - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 37/06 (1970.01) Drugs for immunological or allergic disorders

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/073770 Priority application(s): WO2008/073770

1 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007333321-Coating compositions exhibiting corrosion resistance properties, related coated substrates, and methods

2007333308-Method for reducing the emission of green house gases into the atmosphere